Related Experiment Videos
Translocation of retinoblastoma protein associated with tumor cell growth inhibition
V Rogalsky1, G Todorov, D Moran
1Derald H. Ruttenberg Cancer Center, Mount Sinai Medical Center, New York, NY 10029.
Abstract:
Immunocytochemistry revealed an association between growth inhibition and a translocation of retinoblastoma protein (pRB) to the nucleoli of U-2 osteosarcoma cells inhibited in their growth by the negative growth factor NCPI (natural cell proliferation inhibitor). Similar phenomenon was demonstrated by Western blot analysis and immunocytochemistry in U937 leukemic cells inhibited in their growth and induced to differentiate by 12-O-tetradecanoylphorbol acetate (TPA). Total nuclear extract of control U937 cells gave an intense 110 KD band, while total nuclear extract of TPA treated cells produced an intense 60 KD band and a weak 110 KD band. No bands were observed for the purified nucleoli of control cells, but the purified nucleoli of TPA treated cells produced a 60 KD band. These results suggest that in the process of cell growth inhibition and differentiation, specific proteolysis of pRB and its translocation to the nucleolus may occur.
Insights
Growth inhibition involves retinoblastoma protein (pRB) moving to the nucleoli. This translocation and proteolysis of pRB are observed in both osteosarcoma and leukemic cells during growth inhibition and differentiation.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Retinoblastoma protein (pRB) is a key regulator of cell cycle progression.
- Cell growth inhibition can be induced by specific factors and signaling pathways.
- Nucleolar localization of proteins can indicate specific cellular functions or stress responses.
Purpose of the Study:
- To investigate the subcellular localization of retinoblastoma protein (pRB) during cell growth inhibition.
- To explore the potential role of pRB translocation to the nucleoli in cellular processes like differentiation.
- To identify molecular changes associated with pRB during inhibited growth.
Main Methods:
- Immunocytochemistry was used to visualize pRB localization in U-2 osteosarcoma cells.
- Western blot analysis and immunocytochemistry were performed on U937 leukemic cells.
- Purified nucleoli were analyzed to confirm protein localization.
Main Results:
- Growth inhibition of U-2 osteosarcoma cells by NCPI correlated with pRB translocation to nucleoli.
- Treatment of U937 cells with TPA induced differentiation and altered pRB expression.
- A shift from a 110 KD to a 60 KD pRB band was observed in nuclear extracts, with the 60 KD form found in purified nucleoli of TPA-treated cells.
Conclusions:
- Specific proteolysis of pRB occurs during cell growth inhibition and differentiation.
- Translocation of pRB to the nucleolus is associated with these cellular processes.
- These findings suggest a novel mechanism involving pRB in regulating cell fate decisions.